Clinical Trial: Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07080385) titled 'Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)' on July 14.

Brief Summary: The overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Intervention: DRUG: Encaleret

Oral tablets, age-appropriate pediatric formulation (currently under development).

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Calcilytix Therapeuti...